Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration

Figure 5 Solute carrier family 2 member 1 and solute carrier family 2 member 2 showed negative correlations in hepatocellular carcinoma patients in multiple databases. A: solute carrier family 2 member 1 (SLC2A1) was negatively correlated with solute carrier family 2 member 2 (SLC2A2) in the cohort gene expression series 121248 (r = -0.4756, P < 0.0001); B: SLC2A1 was negatively correlated with SLC2A2 in The Cancer Genome Atlas data (r = -0.28, P = 6.41e-08); C: SLC2A1 was negatively correlated with SLC2A2 in the Tumor Immune Estimation Resource database (r = -0.252, P = 8.4e-07); D: SLC2A1 was negatively correlated with SLC2A2 in the gene expression profiling interactive analysis database (r = -0.19, P = 1.3e-04); TPM: Transcripts per million.